From: Prevalence of microcephaly and Zika virus infection in a pregnancy cohort in Kenya, 2017–2019
Characteristic | Participant 1 | Participant 2 | Participant 3 |
---|---|---|---|
No. of samples positive/tested by ELISA for anti-ZIKV IgM | 3/5 | 2/6 | 3/6 |
No. of samples positive/tested by PRNT | 1/3 | 2/2 | 1/3 |
IgM positive at enrolment | Yes | Yes | No |
Gestational age at PRNT confirmation | • Enrolment at 12.3 weeks | • Enrolment at 13.9 weeks • Follow-up at 24.8 weeks | • Follow-up at 33.3 weeks |
Gestational age at enrolment | 12.3 weeks | 13.9 weeks | 14.3 weeks |
Age in years at enrolment | 30.1 | 36.9 | 21.3 |
HIV infection | Negative | Positive | Negative |
Pregnancy outcome | Lost to follow-up | Live newborn | Live newborn |
Gestational age at delivery | Lost to follow-up | 37.3 | 41.1 |
Small-for-gestational-age newborn | Lost to follow-up | No | No |